BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20832595)

  • 1. Cost of paid transplantation abroad: possible donor-origin early multiple myeloma in a renal transplant recipient treated using bortezomib.
    Solak Y; Atalay H; Anil M; Aydogdu I; Tonbul HZ
    Transplant Proc; 2010 Sep; 42(7):2813-5. PubMed ID: 20832595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient.
    Schlieper G; Kurschat C; Donner A; Huckenbeck W; Rüdiger T; Sandmann W; Grabensee B; Ivens K; Heering P
    Am J Kidney Dis; 2006 Mar; 47(3):e37-41. PubMed ID: 16490613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin.
    Ng IO; Shek TW; Thung SN; Ye MM; Lo CM; Fan ST; Lee JM; Chan KW; Cheung AN
    Mod Pathol; 2000 Nov; 13(11):1180-5. PubMed ID: 11106074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
    Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.
    Libertiny G; Watson CJ; Gray DW; Welsh KI; Morris PJ
    Br J Surg; 2001 Oct; 88(10):1330-4. PubMed ID: 11578286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant multiple myeloma in a pediatric renal transplant patient.
    Tcheng WY; Said J; Hall T; Al-Akash S; Malogolowkin M; Feig SA
    Pediatr Blood Cancer; 2006 Aug; 47(2):218-23. PubMed ID: 16086426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis.
    Caillard S; Agodoa LY; Bohen EM; Abbott KC
    Transplantation; 2006 Mar; 81(6):888-95. PubMed ID: 16570013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
    Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant lymphoproliferative disorders: determination of donor/recipient origin in a large cohort of kidney recipients.
    Olagne J; Caillard S; Gaub MP; Chenard MP; Moulin B
    Am J Transplant; 2011 Jun; 11(6):1260-9. PubMed ID: 21564528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years.
    Abe T; Ichimaru N; Kokado Y; Maeda T; Kakuta Y; Okumi M; Imamura R; Nonomura N; Isaka Y; Takahara S; Okuyama A
    Int J Urol; 2010 Jan; 17(1):48-54. PubMed ID: 20002504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N; Gabdrakhmanova L; Hammer M; Rosenberger C; Oppert M; Volk HD; Reinke P
    Transpl Infect Dis; 2005; 7(3-4):133-6. PubMed ID: 16390402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
    Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
    Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplantation lymphoproliferative disorders in renal transplant recipients: report of over 20 years of experience.
    Saadat A; Einollahi B; Ahmadzad-Asl MA; Moradi M; Nafar M; Pourfarziani V; Firoozan A; Porrezagholi F; Davoudi F
    Transplant Proc; 2007 May; 39(4):1071-3. PubMed ID: 17524894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation.
    Petit B; Le Meur Y; Jaccard A; Paraf F; Robert CL; Bordessoule D; Labrousse F; Drouet M
    Transplantation; 2002 Jan; 73(2):265-71. PubMed ID: 11821742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient.
    Dharnidharka VR; Douglas VK; Hunger SP; Fennell RS
    Pediatr Transplant; 2004 Feb; 8(1):87-90. PubMed ID: 15009846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and consequences of post-transplantation lymphoproliferative disorders.
    Boubenider S; Hiesse C; Goupy C; Kriaa F; Marchand S; Charpentier B
    J Nephrol; 1997; 10(3):136-45. PubMed ID: 9238621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
    J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.